How do cats die with HPN? - briefly
Cats with hepatic portal neoplasia (HPN) typically experience liver failure due to the blockage of blood flow from the intestines to the liver. This often results in rapid deterioration and death within days or weeks after diagnosis.
How do cats die with HPN? - in detail
Hepatic lipidosis, also known as hepatic lipid accumulation or fatty liver disease, is a common condition in cats that can be fatal if not treated promptly and appropriately. When a cat develops hepatic lipidosis, it typically occurs due to a rapid decrease in food intake, leading to an imbalance between the production and utilization of triglycerides. This condition can progress rapidly and is often associated with other underlying diseases such as diabetes, kidney disease, or inflammatory bowel disease.
The primary mechanism behind hepatic lipidosis involves the cat's liver being unable to metabolize fat effectively. Normally, the liver converts fat into energy through a process called beta-oxidation. However, when a cat stops eating or significantly reduces its food intake, the liver starts to break down stored triglycerides for energy. This increased breakdown of triglycerides can overwhelm the liver's capacity to handle the fat, leading to an accumulation of lipids within hepatocytes (liver cells).
As the fatty deposits build up in the liver, they begin to disrupt the normal structure and function of the organ. This disruption can cause hepatocellular injury and inflammation, which further impairs the liver's ability to perform its essential metabolic functions. The accumulation of lipids also interferes with the liver's capacity to produce proteins, leading to a decline in albumin levels and contributing to edema (fluid buildup) in various parts of the body.
The clinical signs of hepatic lipidosis can vary but often include lethargy, anorexia, weight loss, jaundice, and changes in behavior. If left untreated, the condition can progress to liver failure, which is characterized by severe symptoms such as neurological abnormalities, seizures, and coma. In advanced stages, the cat's body may no longer be able to maintain homeostasis, leading to multiple organ failure and ultimately death.
Treatment for hepatic lipidosis focuses on re-establishing normal liver function by addressing the underlying cause of anorexia and providing supportive care. This often involves feeding the cat a high-calorie diet through a nasogastric or esophageal feeding tube to ensure adequate nutrient intake while minimizing stress on the liver. Additionally, intravenous fluid therapy may be necessary to correct dehydration and electrolyte imbalances. Medications such as ursodeoxycholic acid can also be used to support liver function and promote bile flow.
Despite aggressive treatment, the prognosis for cats with hepatic lipidosis can be guarded to poor, particularly if the condition is not diagnosed and treated early. The severity of the disease and the cat's overall health status are crucial factors in determining the outcome. Owners should be aware of the signs of anorexia and promptly seek veterinary care if their cat stops eating or shows other symptoms of hepatic lipidosis. Early intervention and appropriate management can significantly improve the chances of recovery and survival.